𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

✍ Scribed by H. L. Tillmann; J. Hadem; L. Leifeld; K. Zachou; A. Canbay; C. Eisenbach; I. Graziadei; J. Encke; H. Schmidt; W. Vogel; A. Schneider; U. Spengler; G. Gerken; G. N. Dalekos; H. Wedemeyer; M. P. Manns

Book ID
108885854
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
136 KB
Volume
13
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Efficacy of entecavir in patients with c
Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone
✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 287 KB πŸ‘ 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

Clinical and immunological efficacy of i
Clinical and immunological efficacy of intradermal vaccine plus lamivudine with or without interleukin-2 in patients with chronic hepatitis B
✍ Anja Dahmen; Sabine Herzog-Hauff; Wulf O. BΓΆcher; Peter R. Galle; Hanns F. LΓΆhr πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 118 KB πŸ‘ 1 views

## Abstract To evaluate therapeutic immunostimulation nine chronic hepatitis B patients received six monthly intradermal vaccinations with HBsAg in combination with daily lamivudine. Another five patients received six doses of the vaccine and daily lamivudine together with daily Interleukin‐2 (IL‐2